Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on April 15, 2025

MEDĀNA ENTRA EN EL MERCADO ESPAÑOL CON UNA PLATAFORMA DE IA PARA TRANSFORMAR LA SANIDAD EN TODA EUROPA
LISBOA, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- España está a punto de recibir una de las tecnologías más disruptivas en salud digital. Medāna (www.medana.ai), startup internacional fundada por la Dra. Tal Patalon, ha anunciado su entrada estratégica …

Medāna Enters the Netherlands Market with an AI Platform to Transform Healthcare Across Europe
LISBON, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- Netherlands is about to welcome one of the most disruptive technologies in digital health. Medāna (www.medana.ai), the global startup founded by Dr. Tal Patalon, has announced its strategic entry into …

MEDĀNA BETREEDT DE NEDERLANDSE MARKT MET EEN AI-PLATFORM OM DE GEZONDHEIDSZORG TE TRANSFORMEREN IN EUROPA
LISSABON, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- Nederland staat op het punt een van de meest baanbrekende technologieën in de digitale gezondheidszorg te verwelkomen. Medāna (www.medana.ai), de startup opgericht door Dr. Tal Patalon, heeft zijn …

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
MILAN and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Pierluigi Paracchi, CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at “Montalcini Global Biotech Tour” in Doha, Qatar on April …

HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a €21.5 million financing round with …

Vallourec Invitation: Q1 2025 Results Release and Conference Call - Thursday, May 15th, 2025
Q1 2025 Results Release and Conference Call Thursday, May 15th, 2025 Vallourec will publish First Quarter 2025 Results on May 15th, 2025 at 07:30 AM CET. Philippe Guillemot, Chairman of the Board and Chief Executive Officer, and Sascha Bibert, Chief …

Miro Karttunen appointed Managing Director of Colliers in Finland
LONDON, April 15, 2025 (GLOBE NEWSWIRE) -- Global diversified professional services and investment management company Colliers announced today that Miro Karttunen will become the Managing Director (MD) of Colliers in Finland, effective 1 August 2025. …

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …

Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities
CHAPEL-EN-LE-FRITH, United Kingdom, April 15, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences (CLS), a leading integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, today announced key strategic appointments and …

His Majesty’s Treasury appoints Simpson Associates
YORK, United Kingdom, April 15, 2025 (GLOBE NEWSWIRE) -- His Majesty’s Treasury (HMT) has appointed Simpson Associates, leading data transformation consultancy and managed services partner, to support and improve the effective running of its Online System …

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics Cyprumed will be eligible to receive up to $493 million in upfront, development, regulatory and sales milestones INNSBRUCK, Austria, April 15, 2025 …

1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research
Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics, Inc. (1STBIO), a clinical-stage biopharmaceutical …

Echo Sets May 15 as the Global Launch Date for its Centralized Crypto Exchange
Douglas, Isle of Man, April 15, 2025 (GLOBE NEWSWIRE) -- Echo, a groundbreaking centralized cryptocurrency exchange, has announced that it will officially launch globally on May 15, 2025. The much-expected event is set to be a pivotal occasion for digital …

Integral Metals Responds to China’s Rare Earth Export Restrictions, Advancing Exploration at North American Properties
CALGARY, Alberta, April 15, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) recognizes the recent decision by China’s Ministry of Commerce and the General Administration of Customs to …

Holding(s) in Company
Holdings in Company Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, announces it has been informed that Greenstone Resources II LP (“Greenstone”), an existing …

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific …

Progress on share buyback programme
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 12,386,735 shares were repurchased during the week of 7 April 2025 up to and including 11 April 2025. …

Holding(s) in Company
The Board of Serabi announces that the Company has received the following TR-1 notification which is set out below. Serabi Gold plc Michael Hodgson Tel: +44 (0)20 7246 6830 Chief Executive Mobile: +44 (0)7799 473621 Andrew Khov Vice …

Holding(s) in Company
The Board of Serabi announces that the Company has received the following TR-1 notification which is set out below. Serabi Gold plc Michael Hodgson Tel: +44 (0)20 7246 6830 Chief Executive Mobile: +44 (0)7799 473621 Andrew Khov Vice …

Cabka N.V. Publishes 2024 Integrated Annual Report with ESRS-Aligned Sustainability Statement
PRESS RELEASE Amsterdam 15 April 2025. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard-to-recycle plastic waste into innovative Reusable Transport Packaging (RTP), today announces the …